Sheets Smith Wealth Management Gilead Sciences, Inc. Transaction History

Sheets Smith Wealth Management

$828 Million
Q2 2024

A detailed history of Sheets Smith Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 19,995 shares of GILD stock, worth $1.68 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

19,995

Previous 21,720 7.94%

Holding current value

$1.68 Million

Previous $1.59 Million 13.77%

% of portfolio

0.17%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$63.15 - $72.88 $108,933 - $125,717	-1,725 Reduced 7.94%	19,995 $1.37 Million
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $1.5 Million - $1.83 Million	-20,981 Reduced 49.13%	21,720 $1.59 Million
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $1.44 Million - $1.63 Million	19,641 Added 85.17%	42,701 $3.46 Million
Q3 2023 Oct 23, 2023	BUY	$73.94 - $80.67 $295 - $322	4 Added 0.02%	23,060 $1.73 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $22,574 - $25,749	-297 Reduced 1.27%	23,056 $1.78 Million
Q1 2023 May 26, 2023	BUY	$77.31 - $88.08 $1.8 Million - $2.05 Million	23,270 Added 28036.14%	23,353 $1.94 Million
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $1.84 Million - $2.1 Million	-23,821 Reduced 99.65%	83 $6,000
Q4 2022 Mar 08, 2023	SELL	$62.32 - $89.47 $61,260 - $87,949	-983 Reduced 3.95%	23,904 $2.05 Million
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $178,858 - $204,302	3,004 Added 13.73%	24,887 $1.54 Million
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $201,789 - $227,274	-3,496 Reduced 13.78%	21,883 $1.35 Million
Q1 2022 May 02, 2022	SELL	$57.92 - $72.58 $28,786 - $36,072	-497 Reduced 1.92%	25,379 $1.51 Million
Q4 2021 Jan 20, 2022	SELL	$64.88 - $73.64 $7,007 - $7,953	-108 Reduced 0.42%	25,876 $1.88 Million
Q3 2021 Oct 15, 2021	BUY	$67.69 - $73.03 $67 - $73	1 Added 0.0%	25,984 $1.82 Million
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $5,204 - $5,686	82 Added 0.32%	25,983 $1.79 Million
Q1 2021 Apr 23, 2021	BUY	$60.0 - $68.46 $4,020 - $4,586	67 Added 0.26%	25,901 $1.67 Million
Q4 2020 Jan 13, 2021	SELL	$56.65 - $64.55 $8,384 - $9,553	-148 Reduced 0.57%	25,834 $1.51 Million
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $6,147 - $7,729	-99 Reduced 0.38%	25,982 $1.64 Million
Q1 2020 Apr 28, 2020	BUY	$62.63 - $80.22 $14,154 - $18,129	226 Added 0.87%	26,081 $1.95 Million
Q4 2019 Jan 24, 2020	BUY	$61.62 - $67.78 $61 - $67	1 Added 0.0%	25,855 $1.68 Million
Q3 2019 Oct 28, 2019	SELL	$62.51 - $69.0 $305,361 - $337,065	-4,885 Reduced 15.89%	25,854 $1.64 Million
Q2 2019 Jul 12, 2019	BUY	$61.87 - $69.38 $61 - $69	1 Added 0.0%	30,739 $2.08 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $15,632 - $17,512	-250 Reduced 0.81%	30,738 $2 Million
Q4 2018 Jan 11, 2019	BUY	$60.54 - $79.0 $106,005 - $138,329	1,751 Added 5.99%	30,988 $1.94 Million
Q3 2018 Oct 15, 2018	BUY	$71.28 - $78.92 $2,138 - $2,367	30 Added 0.1%	29,237 $2.26 Million
Q2 2018 Jul 26, 2018	SELL	$64.88 - $75.68 $18,815 - $21,947	-290 Reduced 0.98%	29,207 $2.07 Million
Q4 2017 Jan 12, 2018	SELL	$71.15 - $83.52 $101,104 - $118,681	-1,421 Reduced 4.6%	29,497 $2.11 Million
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $2.23 Million - $2.64 Million	30,918	30,918 $2.51 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.

Account

Sheets Smith Wealth Management Gilead Sciences, Inc. Transaction History